title: Expression of telomeric repeat binding factor-1 in astroglial brain tumors.
abstract: OBJECTIVE
  In human somatic cells, telomeres shorten with successive cell divisions, resulting in progressive genomic instability, altered gene expression, and cell death. Recently, telomere-specific deoxyribonucleic acid-binding proteins, such as telomeric repeat binding factor-1 (TRF1), have been proposed as candidates for the role of molecules regulating telomerase activity, and they have been suggested to play key roles in the maintenance of telomere function. The present study was designed to assess TRF1 expression in human astroglial brain tumors and to speculate on the clinical implications of its expression.
  
  
  METHODS
  Twenty flash-frozen surgical specimens obtained from adult patients who underwent craniotomy for microsurgical tumor resection, histologically verified as World Health Organization Grade II to IV astrocytomas, were used. Expression of TRF1 in astrocytomas of different grades was studied by means of both immunohistochemical and Western blotting analysis. The correlation between the extent of TRF1 expression and histological grading, performance status, and length of survival of patients underwent statistical analyses.
  
  
  RESULTS
  TRF1 was expressed in all tumor samples. The level of its expression was variable, decreasing from low-grade through high-grade astrocytomas (P = 0.0032). TRF1 expression correlated with the patient's length of survival (P < 0.001) and performance status (P < 0.001) and proved to be an independent indicator of length of survival.
  
  
  CONCLUSIONS
  Our findings suggest that the loss of TRF1 expression capability, as a result of down-regulation of TRF1 expression in malignant gliomas cells, may play a role in the malignant progression of astroglial brain tumors.
authors.affiliation: Neurosurgical Clinic, Department of Neurosciences, Psychiatric and Anesthesiological Sciences, University of Messina School of Medicine, Messina, Italy.
authors.forename: Domenico
authors.initials: D
authors.lastname: La Torre
authors.forename: Oreste
authors.initials: O
authors.lastname: de Divitiis
authors.forename: Alfredo
authors.initials: A
authors.lastname: Conti
authors.forename: Filippo Flavio
authors.initials: FF
authors.lastname: Angileri
authors.forename: Salvatore
authors.initials: S
authors.lastname: Cardali
authors.forename: M'Hammed
authors.initials: M
authors.lastname: Aguennouz
authors.forename: Marcello
authors.initials: M
authors.lastname: Aragona
authors.forename: Stefania
authors.initials: S
authors.lastname: Panetta
authors.forename: Domenico
authors.initials: D
authors.lastname: d'Avella
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Vita
authors.forename: Francesco
authors.initials: F
authors.lastname: La Torre
authors.forename: Francesco
authors.initials: F
authors.lastname: Tomasello
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001254:Astrocytoma / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D001932:Brain Neoplasms / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D003399:Craniotomy; D005260:Female; D006801:Humans; D008297:Male; D008866:Microsurgery; D008875:Middle Aged; D035321:Telomeric Repeat Binding Protein 1 / Q000235:genetics* / Q000378:metabolism
chemical_list: D035321:Telomeric Repeat Binding Protein 1